Clinical Trial Update: Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Panama [NA]

View source ↗

Summary

First-in-human early feasibility study of the Nanochon chondrograft for knee cartilage lesions. The trial is listed as not yet recruiting in Panama.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Cartilage Lesions

Drugs mentioned

• Nanochon Chondrograft

Snippet

Sponsor: Nanochon, Inc. | Conditions: Knee Cartilage Lesions | NA | Status: NOT_YET_RECRUITING